Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias
Recruiting · NCT06306963 · Observational (researchers observe without assigning treatment) · Lead sponsor: Mayo Clinic
View the official record on ClinicalTrials.gov →Interventions studied
Gastric Emptying Breath Test
What this trial is about
The researchers are trying to find out more about Gastric Antral Vascular Ectasia (GAVE). This is a condition that affects the blood vessels in the stomach, leading to their enlargement and possible bleeding. It can also cause symptoms such as abdominal pain and nausea. By participating in this study, you will help us learn how often these symptoms occur and how they relate to stomach functioning.
Who can take part
Age range
19 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients \>18 years of age with endoscopic evidence of Gastric Antral Vascular Ectasia.
- Willingness to participate in the study
- Capacity to provide informed consent.
- No evidence of organic, systemic, or metabolic disease (e.g. diabetes mellitus) to explain the symptoms on routine investigations
Exclusion criteria
- Patients with transfusion dependent blood loss.
- Patients with severe decompensated liver disease.
- Patients with end stage renal disease.
- Presence of other diseases (structural or metabolic) which could interfere with interpretation of the study results.
- Pregnant or lactating women.
- Patients who have not had a CBC and differential blood draw completed within the last six months.
- Current heavy alcohol use.
Where it is running
1 location listed across 1 US state.
- Mayo Clinic - Rochester, Minnesota, United States